newsfilter
← Latest News
GlobeNewswire·

CorMedix Therapeutics Provides Business Update, Reaffirms 2026 Total Revenue Guidance, and Reports Third Quarter Cash Position

PARSIPPANY, N.J., Nov. 02, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (NASDAQ:CRMD) today provided a business update in advance of a conference call expected to be held on November 12, 2026 to discuss the